GlassScriptPhysician profile
Chad Gier
NPI 1568999555
$39,290.91
in general payments reported to CMS, 2019-2025
24 companies · $24K in 2025
The $24K reported for 2025 was more than what 91% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $218 · 2022: $909 · 2023: $1,699 · 2024: $12K · 2025: $24K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $18K · Consulting Fee: $9,000 · Food and Beverage: $8,418 · Travel and Lodging: $2,561 · Education: $640.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $17,545.40 |
| Consulting Fee | $9,000.00 |
| Food and Beverage | $8,418.16 |
| Travel and Lodging | $2,561.34 |
| Education | $639.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $15,882.42 | 2024-2025 | Carto 3, Nuvision Ice Catheter |
| Boston Scientific Corporation | $7,863.71 | 2024-2025 | General - Therapies, S-Icd System Magnet, Farapulse |
| Abbott Laboratories | $6,692.18 | 2021-2025 | Tacticath, Assurity, Aveir |
| Medtronic, INC. | $6,169.67 | 2024-2025 | Micra, Azure Xt Dr Mri Surescan, Cobalt Dr Mri Surescan |
| Chiesi USA, INC. | $536.03 | 2021-2024 | Kengreal, Cleviprex |
| Amgen INC. | $399.15 | 2022-2024 | Repatha |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $337.73 | 2021-2025 | Lifevest |
| Pfizer INC. | $236.21 | 2021-2024 | |
| Biotronik INC. | $212.95 | 2025 | Acticor 7 Vr-T Dx |
| Boehringer Ingelheim Pharmaceuticals, INC. | $212.14 | 2022-2023 | Jardiance |
| Shockwave Medical, INC | $190.18 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| E.R. Squibb & Sons, L.L.C. | $135.31 | 2022-2024 | Eliquis, Camzyos |
| Astrazeneca Pharmaceuticals LP | $75.95 | 2021-2023 | Farxiga |
| Atricure, INC. | $58.73 | 2024-2025 | Epi-Sense Guided Coagulation System With Visitrax |
| Terumo Medical Corporation | $55.41 | 2021-2024 | Angio-Seal |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $52.85 | 2025 | Evoque |
| Cordis US Corp. | $30.79 | 2024-2025 | Mynx Control Venous, Mynx Control |
| Janssen Scientific Affairs, LLC | $27.24 | 2024 | Xarelto |
| Kiniksa Pharmaceuticals International, Plc | $27.04 | 2024 | Arcalyst |
| Kestra Medical Technology Services, INC. | $26.40 | 2025 | Assure Wcd |
| Cardiva Medical, INC. | $24.75 | 2025 | Cardiva Vascade Mvp Vvcs 6-12f |
| Astellas Pharma US INC | $16.06 | 2021 | |
| Merck Sharp & Dohme LLC | $14.93 | 2023 | Verquvo |
| Novartis Pharmaceuticals Corporation | $13.08 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Chad Gier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.